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Abstract  Control of physiological states such as mean arterial pressure 
(MAP) has been successfully achieved using single drug by different 
control algorithms. Multi-drug delivery demonstrates a significantly 
challenging task as compared to control with a single-drug. Also the 
patient’s sensitivity to the drugs varies from patient to patient. Therefore, 
the implementation of adaptive controller is very essential to improve the 
patient care in order to reduce the workload of healthcare staff and costs. 
This paper presents the design and implementation of the model 
reference adaptive controller (MRAC) to regulate mean arterial pressure 
and cardiac output by administering vasoactive and inotropic drugs that 
are sodium nitroprusside (SNP) and dopamine (DPM) respectively. The 
proposed adaptive control model has been implemented, tested and 
verified to demonstrate its merits and capabilities as compared to the 
existing research work.  
1. Introduction  
The automatic control of physiological parameters has been considered 
as important point for several years. One of the particular problems that 
have been subjected is the control of homodynamic variables such as 
mean arterial pressure (MAP) and cardiac output (CO). The 
implementation of automatic control system is very essential to improve 
the patient care in order to minimising the workload of the physicians and 
reducing the costs. The Cardiovascular system has been used to designs 
control systems for blood pressure control [1]. E. Furutani et al. have 
developed and implemented a state-predictive servo controller for 
continuous feedback control of MAP and inference fuzzy rules to avoid 
the risk and make the patients in safe side during surgical operation [2].   
Over the past several years, different approaches have been investigated. 
Many have focused on the single-input single-output (SISO) control 
systems to lower the patients’ blood pressure and maintain it at desired 
level using single drug particularly sodium nitroprusside (SNP) [3, 4, 5, 6, 
7, 8] and [13]. Fuzzy controller-based MMAC has been presented by H. 
Zheng and K. Zhu in [3]. The patient model and its response to one drug 
have been developed and a nonlinear proportional-integral-derivative PID 
digital controller has been implemented with a minicomputer system to 
control the MAP by infusion SNP [4]. Adaptive proportional-integral (PI) 
controller have been implemented for blood pressure regulation using 
SNP [5]. An integrating self-tuning control strategy has been involved in 
single drug infusion control system to maintain the MAP using SNP [6]. 
The Internal model control (IMC) has been implemented on the patient 
response model to one kind of vasoactive drugs that is SNP [7, 8]. 
Controlling of homodynamic variables commonly using more than one 
drug, A nonlinear electrical analog model with a baroreflex feedback, and 
the MAP was used as the input of a baroreflex to control circulatory 
variables using a computer model [9] and the indirect adaptive controller 
based on recursive identification and linear quadratic regulation has been 
used to control the infusion rates of two drugs [10]. The control advance 
moving average controller (CAMAC) is one kind of adaptive algorithms 
has been implemented to control MAP and CO using two drugs [11]. 
Multiple model adaptive predictive controllers has been designed and 
implemented to regulate MAP and CO by adjusting the infusion rates of 
SNP and DPM [12]. The problem of controlling the cardiovascular 
parameters of a patient using multiple drug administration represents a 
difficult control problem. Blood pressure control by vasoactive drugs is 
essentially a single-input single-output problem and has been successfully 
solved by Sheppard et al [13], using a PID controller. A continuous optimal 
controller and an ARMA discrete controller have been used by Koivo [14, 
15, 16], also, Stern has used a self-tuning regulator [17], and a model 
reference adaptive controller implemented by Kaufman [18, 19].  
This paper focuses on the performance of the model reference adaptive 
control (MRAC) of multi-inputs, multi-outputs system (MIMO). The 
patient model represented by first-order transfer function matrix 2x2 
with time delay [19]. The controller parameters have been adapted using 
the diagonal of time invariant weighting matrices 6x6 [19]. Matlab 
Simulink Toolbox utilized to design and develops the proposed model. 
2. Patient response model  
The patient model represented by two inputs and two outputs system as 
first order model is shown in fig. 1. The objective of the system is to 
decrease a patient’s mean arterial pressure of (20 mmHg) with reference 
signal (-20) and increase the cardiac output of (20 ml/min.kg) with 
reference signal (20). The patient response model is defined by a linear 
small-signal first-order transfer function matrix equation 1as represented 
in [18]. The drugs which have been used to maintain the homodynamic 
variables CO, and MAP are dopamine (DPM) and sodium nitroprusside 
(SNP). The effect of DPM increases both CO and MAP while SNP increases 
CO and decreases MAP. 
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Kij  - Plant gain.            
Tij  – Time delay between the input and the system response. 
τij  - Time constant. 
 
Fig1. Simulink block diagram of the plant model. 
The parameters of the patient model have been represented as nominal 
and ranges values are given in table 1. 
parameters Nominal Ranges Unit 
𝐾11  5 1 to 12 ml/μg 
𝜏11 300 70 to 600 Sec 
𝑇11 60 15 to 60 Sec 
𝐾12  12 -15 to 25 ml/μg 
𝜏12 150 70 to 600 Sec 
𝑇12 50 15 to 60 Sec 
𝐾21 3 0 to 9 𝑚𝑚𝐻𝑔/[𝜇𝑔 𝑚𝑖𝑛. 𝑘𝑔]  
𝜏21 40 30 to 60 Sec 
𝑇21 60 15 to 60 Sec 
𝐾22 -15 -1 to -50 𝑚𝑚𝐻𝑔/[𝜇𝑔 𝑚𝑖𝑛. 𝑘𝑔 ] 
𝜏22 40 30 to 60 Sec 
𝑇22 50 15 to 60 Sec 
Table: 1. 
The desired response of the patient is represented by reference model 
transfer function of CO and MAP as in equation 2, [19]. 
H s =
ym i (s)
um i (s)
=
1
τi s+1
                        (2) 
𝑦𝑚1and 𝑦𝑚2𝑎𝑟𝑒 the outputs of the first and second reference model 
respectively. 
𝑢𝑚1and 𝑢𝑚2𝑎𝑟𝑒 the inputs of the first and second reference model 
respectively. 
𝜏1= 300sec and 𝜏2= 90sec. 
The limitations of drug dosages presented by E.H. Bamey et al [19] are as 
follows:      
0 ≤ 𝐷𝑃𝑀 ≤ 6 𝑚𝑔 𝑚𝑖𝑛. 𝑘𝑔     and    0 ≤ 𝑆𝑁𝑃 ≤ 10 𝑚𝑔 𝑚𝑖𝑛. 𝑘𝑔  
3. Model reference adaptive control 
The patient’s model with model reference adaptive control (MRAC) is 
developed based on the underlying control structure as shown in fig. 2. 
MATLAB function utilized to obtain the reference signal um  depending on 
the patient's case. 
 
Fig2. General form of the patient’s model with MRAC. 
The control u is formulated as a linear combination of the error feedback 
(Kee) and of the two feedforwards reference model output (Kyym ) and 
reference model input (Kuum ). The algorithm applied generically on 
MIMO systems which do not satisfy the perfect model following 
conditions. The order of the plant can be much greater than the order of 
the reference model. The adaptive control law multiplies the values 
available for the measurement the tracking error “e”, the reference 
model output “𝑦𝑚 ” and the reference model input or reference signal 
“um ” with appropriate adaptive gains (Ky , Ku , and Ke). The adaptive 
control law is: 
Up t = Ky t ym t + Ku t um + Ke t [ym t − yp t ]               
(3) 
Up t = Kr t ∗ r t                    (4) 
Kr t =  Ke , Ky , Ku ,               
Kr t = Kp t + K i(t)                  (5) 
r t =  
e(t)
ym (t)
um (t)
 ,   where   e t = ym t − yp (t)             (6) 
The adaptive gains Kr(t) are obtained as a combination of an integral 
gain and a proportional gain as shown below. 
Kp t = e t ∗ r
T ∗ T                                 (7) 
K i t = e t ∗ r
T ∗ T                                 (8) 
As the system has two inputs and two outputs we have designed two 
controllers, the first controller function aims to control the infusion rate 
of the first drug that Dopamine (DPM) and the second controller function 
is to control the infusion rate of the second drug that Sodium 
nitroprusside (SNP). Fig. 3 illustrates the Simulink block diagram of the 
system. 
 
Fig3. Simulink block diagram of the patient model with the MRAC. 
4. Simulation results  
Table 1 presents the nominal and ranges values of the patient’s sensitivity 
to drugs, in order to take into account the different type of patients and 
the patient’s sensitivity to drug varies from patient to patient. Due to that 
the drug infusion controller should be designed to be work well in a real-
time environment for a wide range of patients. In the simulation, 
automatic multiple drug delivery system simulates the MAP and CO using 
DPM and SNP with different sensitivity. The MRAC has been implemented 
to control the infusion rate of the drugs. The controller has adapted using 
the time invariant weighting to make the controller will be suitable for a 
wide range of patients. The system has been tested using different 
patient’s sensitivity, the parameters value of the patient’s model has fixed 
and change just in the values of K22 as (-15, -20, and -50) to expert the 
performance of the controller. Figures 4, 5 and 6 have shown the 
simulation results of the patient responses to drugs, and from that we 
observed the MRAC gives satisfactory results. The results have compared 
to previous work, and from that we observed our simulation has obtained 
better response with almost no overshoot and shorter settling time when 
the patients’ sensitivity was -20. The settling time could be ±2% or ±5% 
from reference point that is (±20.40 or ±21 to ±19.60 or ±19) when the 
reference point set at 20 or -20. The values of diagonal matrix and which 
have been obtained and used to adapt the controller parameters are as 
following: 
T = Diag[1 × 10−5, 2.8 × 10−8, 1.1 × 10−6, 1 × 10−6 , 1 × 10−8, 1 ×
10−10], 
T = Diag[2 × 10−6, 1.6 × 10−4, 2.9 × 10−6, 1 × 10−7 , 4 × 10−10 , 1 ×
10−4]. 
Figures 4, 5 and 6 illustrate the response of patient’s CO and MAP and the 
desired response characteristics which has been represented by model 
response. Also we observed that the range of settling time 508.7 - 1822 
sec for both CO and MAP, without overshoots. 
The simulation results represented that when K12 is -4 the desired 
responses was CO = 19.84 (ml/min.kg) and MAP = -19.96 mmHg from the 
set point and the in-fusion rates of drugs was DPM = 5.993 (mg/min.kg) 
and SNP = 2.534 (mg/min.kg). These results shows that infusion rates of 
DPM and SNP are acceptable, as the infusion rate of DPM did not exceed 
the limit. This clearly demonstrates better performance as compared to 
the result represented by E.H. Bamey, et al [19] as shown in table 2 and G. 
Achuthan [10]. 
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) 
Responses 
C
a
r
d
ia
c 
o
u
tp
u
t -20 
Settling Time (sec) 1232 2790 1440 
Overshoot (ml/min.kg) Zero 0.32 Little 
-50 
Settling Time (sec) 1822 3000 1380 
Overshoot (ml/min.kg) zero 1.23 Little 
M
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-20 
Settling Time (sec) 543.7 700 1320 
Overshoot (mmHg) zero 2.99 1.2 
-50 
Settling Time (sec) 508.7 1360 360 
Overshoot (mmHg) zero 0.82 Zero 
Table: 2. 
Table 2 shows the simulation results of multi-drug infusion control using 
MRAC comparing to previous results and the results which we have 
obtained using non-adaptive PID controller when patients’ sensitivities to 
drug (K22) were -20 and -50. From these results we observed that MRAC 
was satisfied to control simultaneously MAP and CO using two drugs. That 
results have depicted the controller performances in simulation results 
are better with less settling time and without overshoot comparing to the 
performance of non-adaptive PID controller when the patients’ 
sensitivities are -20 and -50, while the performances of the proposed 
algorithm have improved comparing to previous results when K22 is 
equal -20 and without overshoot when the values of K22 equal -20 and -
50. 
Fig4. Patient response (CO and MAP) when 𝐾22= -15.         Fig5. Patient response (CO and MAP) when 𝐾22= -20. 
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      Fig6. Patient response (CO and MAP), when 𝐾22= -50. 
5. Conclusions  
The paper has presented an adaptive multi-drug control scheme for blood pressure 
control. The proposed scheme was designed and evaluated in simulation study to 
maintain the nonlinear responses of CO and MAP using two drugs, namely DPM 
and SNP for the patients of various sensitivities. The simulation results have 
confirmed that MRAC is potentially useful for regulating the MAP and CO by 
computing the DPM and SNP infusion rate. The proposed algorithm demonstrated 
better performance as compared to non-adaptive PID controller and has improved 
compared to reported results when K22  equal -20 with updating the values of the 
controller’s gain. Particularly, the proposed controller offered short settling time 
and very minimum/no overshoot as compared to the existing reported schemes 
when the patient sensitivity K22  less than or equal -20 . As further work, the 
proposed controller will be developed to improve its adaptability more for a wide 
range of patients using more than two drugs. 
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